
Saara Formulations Private Limited
About Saara Formulations Private Limited
Data last updated:
Saara Formulations Private Limited is a private limited company based in Thanjavur, Tamil Nadu, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 08 September 2024.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U21002TN2024PTC173329.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Marimuthu Sakithyan and Porselvam Shanmuganathan.
Its last annual general meeting (AGM) was held on 31 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thanjavur, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹21,845. For the same year it recorded a net loss of ₹1.6 Lakh and EBITDA of -₹1.54 Lakh.
Company details
Contact details
Saara Formulations Private Limited's registered office is in Thanjavur, Tamil Nadu.
- Registered AddressNo. 2840/2A, Nanjikottai Road, Thanjavur, Tamil Nadu, India – 613001
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Saara Formulations Private Limited
FY 2025 filings availableSaara Formulations Private Limited reported revenue of ₹21,845 for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | -₹1.54 Lakh |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹1.6 Lakh |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2024-25 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Saara Formulations Private Limited, buy the company report.
Board of directors of Saara Formulations Private Limited
Saara Formulations has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Marimuthu Sakithyan | Director | 08 Sep 2024 | 2 Years 1 Months | Current |
| Porselvam Shanmuganathan | Director | 08 Sep 2024 | 2 Years 1 Months | Current |
| Dhandayutham Sangeetha | Individual Subscriber | 08 Sep 2024 | 2 Years 1 Months | Current |
Peer comparison
Saara Formulations Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| MC Medibio Life Science Private Limited | ₹23,000 (FY 2023) | -100.0% | Chennai, Tamil Nadu, India | |||
| Silicon Drugs & Intermediates Private Limited | ₹23,000 (FY 2025) | 475.0% | Hyderabad, Telangana, India | |||
| Gpcity Crown World Private Limited | ₹22,851 (FY 2021) | Delhi, India | ||||
| Tradmod Lifesciences Private Limited | ₹22,765 (FY 2022) | -44.0% | New Delhi, Delhi, India | |||
| Sanatra Pharma Private Limited | ₹22,500 (FY 2022) | -6.0% | Kolkata, West Bengal, India | |||
| Saara Formulations Private Limitedthis company | ₹21,845 (FY 2025) | -₹1.6 Lakh | Thanjavur, Tamil Nadu, India | |||
| KBH Resins Private Limited | ₹21,842 (FY 2025) | Ahmedabad, Gujarat, India | ||||
| Jaysons Api Private Limited | ₹21,224 (FY 2024) | 36.0% | Kolkata, West Bengal, India | |||
| Esthers & Morris Tradecom Private Limited | ₹21,208 (FY 2023) | -98.0% | Dehradun, Uttarakhand, India | |||
| Alliant Lifesciences Private Limited | ₹21,032 (FY 2023) | -95.0% | Mumbai, Maharashtra, India | |||
| Yashvi Pharma Private Limited | ₹21,000 (FY 2025) | Ahmedabad, Gujarat, India |
To see the full peer comparison of Saara Formulations Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Saara Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Saara Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Saara Formulations Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Saara Formulations Private Limited has 4 board changes on record since 2024: 3 appointments and 1 cessation. The latest: Saravanamuthu Marimuthu ceased to be Director on 25 Oct 2024.
Frequently asked questions
Saara Formulations is an active private limited company based in Thanjavur, Tamil Nadu, India. The company works in paper and paper products, within the paper industry. It was incorporated on 08 September 2024 (2+ years old) and is registered under CIN U21002TN2024PTC173329.
Saara Formulations has 3 current directors:
- Marimuthu Sakithyan - Director
- Porselvam Shanmuganathan - Director
- Dhandayutham Sangeetha - Individual Subscriber
The latest financial statements of Saara Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 December 2025. Year-wise statements from FY 2025 are in the company report.
The CIN (Corporate Identification Number) of Saara Formulations is U21002TN2024PTC173329. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Saara Formulations was incorporated on 08 September 2024, making it 2+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Saara Formulations by revenue are MC Medibio Life Science Private Limited, Silicon Drugs & Intermediates Private Limited, Gpcity Crown World Private Limited, Tradmod Lifesciences Private Limited, Sanatra Pharma Private Limited and 5 more, all in the Pharma industry (Formulations).
Saravanamuthu Marimuthu ceased to be Director on 25 Oct 2024. Dhandayutham Sangeetha was appointed as Individual Subscriber on 08 Sep 2024. Marimuthu Sakithyan was appointed as Director on 08 Sep 2024. Saara Formulations has 4 board changes on record in total.
The registered office of Saara Formulations is at No. 28402A, Nanjikottai Road, Thanjavur, Tamil Nadu, India – 613001.
Saara Formulations operates in the paper industry, in the paper and paper products segment.
Saara Formulations can be reached at its registered office: No. 28402A, Nanjikottai Road, Thanjavur, Tamil Nadu, India – 613001.
Saara Formulations is registered under the jurisdiction of the Registrar of Companies (ROC), Chennai.

